0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Tackling Lassa fever misinformation and vaccine hesitancy through culturally-tailored health dialogues in Northern Nigeria [Conference Abstract] August 18, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Vaccination intentions, readiness, and preferred attributes of a future Lassa fever vaccine among staff at a tertiary hospital in Edo State, Nigeria: A cross-sectional survey [Conference Abstract] August 17, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Understanding gender dynamics, consent experiences, and community engagement in clinical trials in the context of a Lassa fever vaccine trial in Ghana [Conference Abstract] August 17, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Sociocultural and environmental risk factors sustaining Lassa fever transmission in endemic communities of Edo State, Nigeria: Implications for targeted prevention strategies [Conference Abstract] August 17, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Vaccines against Lassa fever virus (VITAL): Phase 1 safety and immunogenicity studies of a Lassa fever vaccine, ChAdOx1 LassaJ, in healthy volunteers in the UK and Ghana [Conference Abstract] August 16, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Early dialysis and innovations for better outcome in Lassa fever patients with acute kidney injury [Conference Abstract] August 16, 2025 by Allan Mwesiga
